Vascular Stents Market Size, Share, Trends, Demand & Growth Analysis 2024 to 2029

Vascular stents are small, expandable metal/polymer mesh tubes used in medical procedures to keep narrowed or blocked blood vessels open. They are typically inserted during angioplasty, a minimally invasive procedure where a balloon-tipped catheter is used to widen the vessel. Once the artery is opened, the stent remains in place to provide structural support, preventing re-narrowing of the vessel, a condition known as restenosis. There are various types of stents, including drug-eluting stents that release medication to further reduce the risk of restenosis.

Rising Prevalence of Cardiovascular Diseases (CVDs) to Drive Market Growth

​Cardiovascular Diseases CVDs, including coronary artery disease, peripheral artery disease, and atherosclerosis, are increasing due to factors like aging populations, unhealthy lifestyles, obesity, and diabetes. According to WHO CVDs are the leading cause of death globally, taking an estimated 17.9 million lives each year. In 2019, approximately 17.9 million people died from CVDs, accounting for 32% of all global deaths. Of these, 85% were due to heart attacks and strokes. These conditions lead to the narrowing or blockage of arteries, requiring interventions such as angioplasty with stenting to restore blood flow. Vascular stents, particularly drug-eluting and bioresorbable types, offer effective solutions to prevent restenosis after balloon angioplasty, improving patient outcomes. With the global burden of CVDs rising, the demand for minimally invasive procedures like stenting is growing. This trend is further supported by the increasing availability of healthcare infrastructure and rising awareness of cardiovascular health in both developed and developing regions. As a result, the market for vascular stents is expected to expand, driven by the need to address CVD-related complications and improve treatment outcomes for the growing number of patients affected by these diseases.

“There is a growing preference for minimally invasive surgeries due to their associated benefits, such as reduced recovery times and lower complication rates. This trend is driving the adoption of vascular stents over traditional surgical methods"- Consultant Cardiologist, A Leading Hospital Group, United States

Growing Preference for Minimally Invasive Procedures to Fuel Market Growth

Minimally invasive techniques, such as percutaneous coronary intervention (PCI), which involves placing a vascular stent, have become the preferred method for treating CVDs like coronary artery disease and peripheral artery disease. These procedures offer several benefits over traditional surgical interventions, such as reduced recovery times, lower risk of complications, shorter hospital stays, and minimal scarring, which are highly appealing to both patients and healthcare providers. Advancements in stent technologies, including drug-eluting stents (DES) and bioresorbable stents, have further improved the outcomes of minimally invasive procedures by reducing the risk of restenosis and enhancing long-term safety. These innovations have made stenting a reliable option for a wide range of patients, including those who may not be suitable candidates for more invasive surgical procedures like coronary artery bypass grafting (CABG). The increasing adoption of minimally invasive procedures is particularly prominent in developed regions, where healthcare infrastructure is advanced, and patients have access to cutting-edge treatments. However, the trend is also gaining momentum in emerging markets due to the rising awareness of CVD treatment options and improving healthcare systems. This preference for less invasive interventions is expected to drive the demand for vascular stents, as these procedures become a cornerstone in the treatment of CVDs, contributing to the overall growth of the vascular stents market.

To learn more about this report, download the PDF brochure

Expansion of Bioabsorbable Stents: A Major Market Opportunity

The expansion of bioabsorbable stents presents a major market opportunity in the vascular stents sector due to their potential to overcome limitations of traditional metal stents. Unlike permanent metal stents, bioabsorbable stents are designed to dissolve naturally over time, reducing long-term complications such as stent thrombosis, inflammation, and the need for future interventions. These stents provide structural support to arteries after angioplasty but gradually degrade, allowing the vessel to regain natural function without the risk of permanent foreign material remaining in the body. This is particularly advantageous for younger patients or those with less severe blockages, where long-term stent presence may pose risks. Growing awareness of the benefits of bioabsorbable stents, along with advancements in material science and improved clinical outcomes, is driving their adoption. The expanding demand for minimally invasive and innovative solutions in cardiovascular treatments, coupled with increasing healthcare investments in emerging markets, further enhances the opportunity for bioabsorbable stents. As these stents become more widely available and affordable, they are expected to capture a significant share of the vascular stents market, propelling its growth.

North America Expected to be a Major Growth Engine in the Vascular Stents Market

North America is expected to be a major growth engine in the vascular stents market due to several factors. The region has a high prevalence of cardiovascular diseases (CVDs), driven by lifestyle-related conditions such as obesity, diabetes, and hypertension. This, combined with an aging population, is significantly increasing the demand for vascular stents. Additionally, North America is home to advanced healthcare infrastructure and cutting-edge medical technologies, making it a hub for the adoption of innovative stent solutions, such as drug-eluting and bioresorbable stents. The region also benefits from strong reimbursement policies, which make stenting procedures more accessible to a broader patient population. Moreover, key players in the vascular stents industry, headquartered in North America, are continuously investing in research and development to improve stent technology, further driving market growth. The increasing awareness of minimally invasive procedures and the presence of well-established healthcare facilities make North America a key driver of the global vascular stents market. The growth in APAC is driven by the rising prevalence of cardiovascular diseases due to aging populations and lifestyle changes. Improving healthcare infrastructure, increased spending, and government investments in countries like China, India, and Japan are expanding access to stenting procedures, further boosting demand.

To learn more about this report, download the PDF brochure

Product Type Segment Analysis

The vascular stents market comprises of product types like: Coronary stents (Peripheral stents, Carotid artery stents, Renal artery stents, Femoral artery stents, Iliac artery stents, Other peripheral stents) and EVAR Stent Grafts (Abdominal aortic aneurysm stent grafts, and Thoracic aortic aneurysm stent grafts). Coronary stents represent the largest segment due to their widespread use in treating coronary artery disease, which remains a leading health concern globally. This segment benefits from high procedural volumes, technological advancements like drug-eluting stents, and favorable clinical outcomes, solidifying its dominance. The EVAR stent grafts segment, particularly for abdominal aortic aneurysm stent grafts, is the is expected to register a significant growth over the forecast period. This growth is driven by an increasing prevalence of aortic aneurysms and rising awareness of endovascular techniques, which offer less invasive treatment options. As the population ages and more patients are diagnosed, the demand for EVAR stent grafts is expected to surge, contributing significantly to market expansion in the coming years.

End User Type Segment Analysis

The vascular stents market can be analyzed based on end user types, such as Hospitals, Cardiac Centers, Ambulatory Surgical Centers (ASCs), and Others. Hospitals represent the largest segment due to their comprehensive facilities, skilled personnel, and the ability to handle complex procedures. Hospitals offer a wide range of vascular interventions and are equipped with advanced imaging and surgical technologies, making them the primary choice for stent placements. On the other hand, ASCs are gaining popularity due to their cost-effectiveness, shorter patient wait times, and convenience. As healthcare providers increasingly focus on outpatient procedures, ASCs are becoming a preferred option for elective vascular interventions, leading to their rapid expansion in the market. The shift towards minimally invasive procedures and the rising demand for same-day discharge are further driving growth in this segment.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market

Players operating in this market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner market share. For instance,

• In September 2024, Boston Scientific acquired Silk Road Medical for approximately USD 1.26 billion, enhancing its offerings in stroke prevention through Silk Road’s innovative stent technology used in transcarotid artery revascularization (TCAR)
• In May 2024, Abbott launched the XIENCE Sierra Everolimus-eluting coronary stent system in India, designed to enhance safety and efficacy for patients with blocked coronary arteries. This next-generation stent features an improved design and delivery system, aiming to help interventional cardiologists tackle complex cases and improve patient outcomes amid rising rates of coronary artery disease in the country
• In December 2023, Terumo India (the Indian arm of Japan-based Terumo Corporation) launched the Ultimaster Nagomi, a new drug-eluting stent for treating coronary artery disease in India
• In August 2022, Medtronic launched the Onyx Frontier drug-eluting coronary stent, following CE Mark approval, which features an innovative dual-layer balloon and enhanced delivery system for improved performance in challenging cases. Building on the Resolute Onyx™ platform, the Onyx Frontier DES offers a broad size range for treating coronary artery disease and maintains approval for various complex indications

The vascular stents market is anticipated to experience significant growth in the upcoming years due to technological advancements, rising R&D investments, and aggressive organic and inorganic growth strategies followed by the players.

Competitive Landscape Analysis

The global vascular stents market is marked by the presence of established market players such as Abbott Laboratories; B. Braun SE; Becton, Dickinson, and Company; Biotronik SE & Co. KG; Boston Scientific Corporation; Medtronic Plc; Shanghai MicroPort Medical (Group) Co., Ltd.; Stryker Corporation; Terumo Corporation; and W.L. Gore & Associates, Inc, among others.

Get a sample report for competitive landscape analysis

Future Outlook of the Vascular Stents Market

The global vascular stents market is expected to gain further momentum in the coming years due to the increased awareness about the risks of vascular disease, advancements in healthcare facilities and technologies, and a rising preference for interventional procedures over traditional surgical methods. These factors collectively contribute to the growth and evolution of the vascular stents market.

Vascular Stents Market Scope

Key Strategic Questions Addressed

• What is the market size & forecast for the Global Vascular Stents Market?

• What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the Global Vascular Stents Market?

• How has COVID-19 impacted the Global Vascular Stents Market?

• What are the major growth drivers, restraints/challenges impacting the market?

• What are the opportunities prevailing in the market?

• What is the investment landscape?

• Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?

• Who are the major players operating in the market? What is the competitive positioning of key players?

• Who are the new players entering the market?

• What are the key strategies adopted by players?